287 related articles for article (PubMed ID: 27206958)
1. Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodents.
Kopruszinski CM; Xie JY; Eyde NM; Remeniuk B; Walter S; Stratton J; Bigal M; Chichorro JG; Dodick D; Porreca F
Cephalalgia; 2017 May; 37(6):560-570. PubMed ID: 27206958
[TBL] [Abstract][Full Text] [Related]
2. Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache.
Navratilova E; Behravesh S; Oyarzo J; Dodick DW; Banerjee P; Porreca F
Cephalalgia; 2020 Aug; 40(9):892-902. PubMed ID: 32615788
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache.
Rau JC; Navratilova E; Oyarzo J; Johnson KW; Aurora SK; Schwedt TJ; Dodick DW; Porreca F
Cephalalgia; 2020 Aug; 40(9):903-912. PubMed ID: 32580575
[TBL] [Abstract][Full Text] [Related]
4. CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice.
Navratilova E; Rau J; Oyarzo J; Tien J; Mackenzie K; Stratton J; Remeniuk B; Schwedt T; Anderson T; Dodick D; Porreca F
Cephalalgia; 2019 Dec; 39(14):1762-1775. PubMed ID: 31550910
[TBL] [Abstract][Full Text] [Related]
5. A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.
Kopruszinski CM; Navratilova E; Swiokla J; Dodick DW; Chessell IP; Porreca F
Cephalalgia; 2021 Mar; 41(3):305-317. PubMed ID: 32985222
[TBL] [Abstract][Full Text] [Related]
6. Triptan-induced latent sensitization: a possible basis for medication overuse headache.
De Felice M; Ossipov MH; Wang R; Lai J; Chichorro J; Meng I; Dodick DW; Vanderah TW; Dussor G; Porreca F
Ann Neurol; 2010 Mar; 67(3):325-37. PubMed ID: 20373344
[TBL] [Abstract][Full Text] [Related]
7. Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache.
Nation KM; Dodick DW; Navratilova E; Porreca F
Cephalalgia; 2019 Apr; 39(5):617-625. PubMed ID: 30286616
[TBL] [Abstract][Full Text] [Related]
8. Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache.
Green AL; Gu P; De Felice M; Dodick D; Ossipov MH; Porreca F
Cephalalgia; 2014 Jul; 34(8):594-604. PubMed ID: 24335852
[TBL] [Abstract][Full Text] [Related]
9. Enhanced post-traumatic headache-like behaviors and diminished contribution of peripheral CGRP in female rats following a mild closed head injury.
Bree D; Mackenzie K; Stratton J; Levy D
Cephalalgia; 2020 Jun; 40(7):748-760. PubMed ID: 32077327
[TBL] [Abstract][Full Text] [Related]
10. Early Effect of Calcitonin Gene-related Peptide Monoclonal Antibodies in Migraine with Medication Overuse: A Single-center Retrospective Study.
Ito Y; Mitsufuji T; Okada M; Fujita S; Yokoyama R; Kawasaki H; Yamamoto T
Intern Med; 2023 Dec; 62(23):3455-3460. PubMed ID: 37062749
[TBL] [Abstract][Full Text] [Related]
11. Development of CGRP-dependent pain and headache related behaviours in a rat model of concussion: Implications for mechanisms of post-traumatic headache.
Bree D; Levy D
Cephalalgia; 2018 Feb; 38(2):246-258. PubMed ID: 27899434
[TBL] [Abstract][Full Text] [Related]
12. Opiate-induced persistent pronociceptive trigeminal neural adaptations: potential relevance to opiate-induced medication overuse headache.
De Felice M; Porreca F
Cephalalgia; 2009 Dec; 29(12):1277-84. PubMed ID: 19438917
[TBL] [Abstract][Full Text] [Related]
13. A Monoclonal Anti-Calcitonin Gene-Related Peptide Antibody Decreases Stress-Induced Colonic Hypersensitivity.
Noor-Mohammadi E; Ligon CO; Mackenzie K; Stratton J; Shnider S; Greenwood-Van Meerveld B
J Pharmacol Exp Ther; 2021 Nov; 379(3):270-279. PubMed ID: 34620725
[TBL] [Abstract][Full Text] [Related]
14. Trigeminal Pain Molecules, Allodynia, and Photosensitivity Are Pharmacologically and Genetically Modulated in a Model of Traumatic Brain Injury.
Daiutolo BV; Tyburski A; Clark SW; Elliott MB
J Neurotrauma; 2016 Apr; 33(8):748-60. PubMed ID: 26472135
[TBL] [Abstract][Full Text] [Related]
15. Circulating nociceptin and CGRP in medication-overuse headache.
Munksgaard SB; Ertsey C; Frandsen E; Bendtsen L; Tekes K; Jensen RH
Acta Neurol Scand; 2019 Mar; 139(3):269-275. PubMed ID: 30457160
[TBL] [Abstract][Full Text] [Related]
16. Is prednisone still a reasonable option in the treatment of withdrawal headache in patients with chronic migraine and medication overuse headache in the age of CGRP antibodies? A narrative review.
Kaltseis K; Hamann T; Gaul C; Broessner G
Headache; 2022 Nov; 62(10):1264-1271. PubMed ID: 36437611
[TBL] [Abstract][Full Text] [Related]
17. Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine.
Kopruszinski CM; Thornton P; Arnold J; Newton P; Lowne D; Navratilova E; Swiokla J; Dodick DW; Dobson C; Gurrell I; Chessell IP; Porreca F
Cephalalgia; 2020 Dec; 40(14):1535-1550. PubMed ID: 33131305
[TBL] [Abstract][Full Text] [Related]
18. Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models.
Avona A; Burgos-Vega C; Burton MD; Akopian AN; Price TJ; Dussor G
J Neurosci; 2019 May; 39(22):4323-4331. PubMed ID: 30962278
[TBL] [Abstract][Full Text] [Related]
19. Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.
Xie JY; De Felice M; Kopruszinski CM; Eyde N; LaVigne J; Remeniuk B; Hernandez P; Yue X; Goshima N; Ossipov M; King T; Streicher JM; Navratilova E; Dodick D; Rosen H; Roberts E; Porreca F
Cephalalgia; 2017 Jul; 37(8):780-794. PubMed ID: 28376659
[TBL] [Abstract][Full Text] [Related]
20. Release of calcitonin gene-related peptide (CGRP) from guinea pig dura mater in vitro is inhibited by sumatriptan but unaffected by nitric oxide.
Eltorp CT; Jansen-Olesen I; Hansen AJ
Cephalalgia; 2000 Nov; 20(9):838-44. PubMed ID: 11167915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
